Comparison Overview

Olympus Corporation

VS

Edwards Lifesciences

Olympus Corporation

Nishi-shinjuku 2-3-1 Shinjuku Monolith, None, Shinjuku-ku, Tokyo, JP, None
Last Update: 2025-12-09

Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 10,074
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Edwards Lifesciences

One Edwards Way, None, Irvine, CA, US, 92614
Last Update: 2025-12-09
Between 800 and 849

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more.  Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 13,399
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/olympus-corp.jpeg
Olympus Corporation
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/edwards-lifesciences.jpeg
Edwards Lifesciences
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Olympus Corporation
100%
Compliance Rate
0/4 Standards Verified
Edwards Lifesciences
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Olympus Corporation in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Edwards Lifesciences in 2025.

Incident History — Olympus Corporation (X = Date, Y = Severity)

Olympus Corporation cyber incidents detection timeline including parent company and subsidiaries

Incident History — Edwards Lifesciences (X = Date, Y = Severity)

Edwards Lifesciences cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/olympus-corp.jpeg
Olympus Corporation
Incidents

No Incident

https://images.rankiteo.com/companyimages/edwards-lifesciences.jpeg
Edwards Lifesciences
Incidents

No Incident

FAQ

Edwards Lifesciences company demonstrates a stronger AI Cybersecurity Score compared to Olympus Corporation company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Edwards Lifesciences company has disclosed a higher number of cyber incidents compared to Olympus Corporation company.

In the current year, Edwards Lifesciences company and Olympus Corporation company have not reported any cyber incidents.

Neither Edwards Lifesciences company nor Olympus Corporation company has reported experiencing a ransomware attack publicly.

Neither Edwards Lifesciences company nor Olympus Corporation company has reported experiencing a data breach publicly.

Neither Edwards Lifesciences company nor Olympus Corporation company has reported experiencing targeted cyberattacks publicly.

Neither Olympus Corporation company nor Edwards Lifesciences company has reported experiencing or disclosing vulnerabilities publicly.

Neither Olympus Corporation nor Edwards Lifesciences holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Olympus Corporation company nor Edwards Lifesciences company has publicly disclosed detailed information about the number of their subsidiaries.

Edwards Lifesciences company employs more people globally than Olympus Corporation company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Olympus Corporation nor Edwards Lifesciences holds SOC 2 Type 1 certification.

Neither Olympus Corporation nor Edwards Lifesciences holds SOC 2 Type 2 certification.

Neither Olympus Corporation nor Edwards Lifesciences holds ISO 27001 certification.

Neither Olympus Corporation nor Edwards Lifesciences holds PCI DSS certification.

Neither Olympus Corporation nor Edwards Lifesciences holds HIPAA certification.

Neither Olympus Corporation nor Edwards Lifesciences holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, there is no handler for JSON parsing errors; SyntaxError from express.json() includes user input in the error message, which gets reflected in responses. User input (including HTML/JavaScript) can be exposed in error responses, creating an XSS risk if Content-Type isn't strictly enforced. This issue does not have a fix at the time of publication.

Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when creating prompts, JSON requests are sent to define and modify the prompts via PATCH endpoint for prompt groups (/api/prompts/groups/:groupId). However, the request bodies are not sufficiently validated for proper input, enabling users to modify prompts in a way that was not intended as part of the front end system. The patchPromptGroup function passes req.body directly to updatePromptGroup() without filtering sensitive fields. This issue is fixed in version 0.8.1.

Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when a user posts a question, the iconURL parameter of the POST request can be modified by an attacker. The malicious code is then stored in the chat which can then be shared to other users. When sharing chats with a potentially malicious “tracker”, resources loaded can lead to loss of privacy for users who view the chat link that is sent to them. This issue is fixed in version 0.8.1.

Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

MaxKB is an open-source AI assistant for enterprise. Versions 2.3.1 and below have improper file permissions which allow attackers to overwrite the built-in dynamic linker and other critical files, potentially resulting in privilege escalation. This issue is fixed in version 2.4.0.

Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Description

MaxKB is an open-source AI assistant for enterprise. In versions 2.3.1 and below, the tool module allows an attacker to escape the sandbox environment and escalate privileges under certain concurrent conditions. This issue is fixed in version 2.4.0.

Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H